Noteworthy, in keeping with preclinical data, in the subgroup of ERα-negative tumors, a significantly higher TAM infiltration was found in premenopausal compared to postmenopausal patients, this confirming a role of systemic estrogens in altering tumor microenvironment, independently of their direct effect on tumor cell growth. This evidence concerns the gene ESR1 and neoplasm.